Erez Chimovits

BRVE

Erez Chimovits serves as director, 10 percent owner: at BRVE (BRVE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$48.95M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$48.95M

Companies Traded

BRVE, UPB

Active Period

Oct 2024 – Aug 2026

2 total trades

Most Recent

Buy BRVE

Aug 11, 2026 · $34.92M

Erez Chimovits's Insider Trading at BRVE (BRVE)

Buys

1 · $34.92M

Sells

0 · $0.00

Total Shares Bought

1,940,000

Total Shares Sold

BRVE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 11, 2026	Buy	1,940,000	$18.00	$34.92M	11,901,826

Erez Chimovits's Insider Trading at Upstream Bio, Inc. (UPB)

Buys

1 · $14.03M

Sells

0 · $0.00

Total Shares Bought

825,000

Total Shares Sold

UPB Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 17, 2024	Buy	825,000	$17.00	$14.03M	4,554,873

Related Insiders

Everett Rand Sutherland

director, officer: Chief Executive Officer

UPBSell · Sep 17, 2026

Allison Ambrose

officer: General Counsel

UPBSell · Sep 17, 2026

GRAY MICHAEL

officer: CFO and COO

UPBSell · Sep 17, 2026

Aaron Deykin

officer: Chief Medical Officer

UPBSell · Sep 17, 2026

Adam Houghton

officer: Chief Business Officer

UPBSell · Sep 17, 2026

ORBIMED ADVISORS LLC

director, 10 percent owner:

BRVEBuy · Aug 11, 2026

AH Bio Fund IV, L.P.

10 percent owner

BRVEBuy · Aug 11, 2026

Christopher Viehbacher

director

BRVEBuy · Aug 7, 2026

Explore More Insider Trading Data

BRVE Insider Trading Activity

View all insider trades at BRVE

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity